FDA Approves First Drug To Boost Women’s Sexual Desire

The decision was welcomed by some doctors and women’s advocates, who said they hoped it would open to the door to more drugs to help women with sexual problems.

‘Clearly we need more than just one medication — women need to have an array of choices that meets their specific medical needs,’ says Terry O’Neill of the National Organization for Women. ‘So with this success I think there will be more development of more medications. And that is all to the good.’

‘The Seventies’: Feminism makes waves

Ryan Bergeron writes for CNN: “The National Organization for Women, which was founded in 1966 and advocated for a “fully equal partnership of the sexes,” soon endorsed the ERA and made passing it into the U.S. Constitution a top priority. (The amendment had been unsuccessfully presented to every session of Congress between 1923 and 1970.)”

This Day in History: National Organization for Women was Founded

On June 30, 1966, Betty Friedan wrote three letters on a paper napkin: N O W. She invited fifteen women to her hotel room. Then, Catherine Conroy slid a five-dollar bill onto the table and said, “Put your money down and sign your name.” In that moment, the National Organization for Women became a reality.

As representatives at the Third National Conference of Commissions on the Status of Women, these women were disgruntled by the lack of commitment to the convention’s theme, “Targets for Action.” Inspired by the Civil Rights movement and historic marches such as in Selma, the women founded a parallel effort to ensure the equal treatment of both sexes. They brainstormed an alternate action plan to enforce Title VII of the Civil Rights Act of 1964, which prohibits employers from discriminating against employees based on sex, race, color, nationality, and religion.

The fight for a ‘female Viagra’

“It looks to me like there are more hurdles being put in front of this drug than there have been on drugs addressing male dysfunction,” Terry O’Neill, president of the National Organization for Women, told The Washington Post after flibanserin was rejected a second time. “Obviously, everyone only wants drugs to get on the market if they are proven safe and effective. But we don’t want attitudes to get in the way of a good drug.”